Truncation [Regulatives / Guidelines]

posted by hiren379 – India, 2012-08-14 14:01 (5065 d 02:54 ago) – Posting: # 9060
Views: 5,795

Hello all,
How to prove that there is no high variability in Distribution and Clearance phase for using truncated AUC approach for USFDA?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
195 visitors (0 registered, 195 guests [including 19 identified bots]).
Forum time: 16:56 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5